TP53 and diffuse intrinsic pontine glioma: As it is a multi-kinase inhibitor with several therapeutic targets of relevance to DIPG (Table 2), we chose to further investigate its efficacy by using the PDGF-B; H3.3K27M; p53 deficient DIPG model both in vitro and in vivo.